Scotland weighs screening and other lab developments to tackle TB
This article was originally published in Clinica
Executive Summary
Scotland has announced plans to develop a TB strategy focusing on surveillance, screening and laboratory services, among other issues. The announcement was made today, to mark World TB Day, which also saw the publication of a Scottish version of the National Institute for Health and Clinical Excellence (NICE) guidelines "Clinical diagnosis and management of TB and measures for its prevention". Public health minister Shona Robison said that a working group of experts, including from the UK-wide Health Protection Agency, will be expected to draw up a draft of the strategy by the end of this year.
You may also be interested in...
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.